The U.S. Defense Health Agency awarded a $1,295,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to ST Jude Children's Research Hospital Inc. in Memphis, Tennessee. The grant, with a performance period from September 1, 2024 to August 31, 2028, will support research to create cures for patients with Langerhans Cell Histiocytosis, a rare and serious pediatric disease. ST Jude Children's Research Hospital Inc., a nonprofit medical research organization, has a history of federal grant and contract awards for pediatric cancer, infectious disease, and other life-threatening illness research. This award reflects the agency's strategic focus on advancing innovative medical solutions to improve health outcomes for military personnel and the general public.
Generated 3/4/25, 5:55 AM